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Abstract
Purpose The purpose of this study is to report a case of
bilateral nodular scleritis in a patient with final diagnosis of
IgA nephropathy.
Methods This is an observational case report.
Results A male patient, 42 years old, presented with a
bilateral nodular scleritis and OD sclerokeratitis. He had a
previous history of acute otitis media and developed poste-
rior renal failure and arterial hypertension. Clinical and
systemic findings suggest Wegener's granulomatosis. A kid-
ney biopsy was performed, and immunoflourescence find-
ings demonstrated granular deposits of IgA in a mesangial
pattern confirming the diagnosis of IgA nephropathy
Conclusions IgA nephropathy should be a differential diag-
nosis in patients with scleritis and nephropathy.
Keywords
Introduction
Scleritis may occur as an isolated phenomenon or as a
manifestation of a variety of rheumatic disorders, infectious
diseases, and metabolic disorders [1]. Scleritis is associated
with systemic disease in approximately 50% of cases [2];
however, it is not frequent in IgA nephropathy (IgAN).
IgAN, first described by Berger in 1969 [3], is one of
the most common primary glomerulopathies worldwide
[4]. The disease is diagnosed by renal biopsy using
histopathologic and immunoflourescence tests. The hall-
mark of IgAN is macroscopic hematuria that usually
occurs with or immediately after an upper airway infec-
tion [5]. Other characteristic manifestations are: painless
episodic hematuria, proteinuria, hypertension, and renal
impairment. IgA nephropathy was previously thought to
be a benign disease with a 10-year renal survival rate
greater than 80%, but emerging data show a different
scenario. Most patients develop a progressive decline in
renal function, and about 40% present end-stage renal
failure [6]. Although IgAN is clinically limited to the
kidneys in most cases, there are associations with other
conditions, particularly with immune and inflammatory
diseases, such as ankylosing spondylitis, rheumatoid ar-
thritis, Reiter syndrome and Behcet's disease, celiac dis-
ease, alcoholic and non-alcoholic liver disease, hepatic
schistosomiasis, pulmonary sarcoidosis, and dermatitis
herpetiformis [7].
Ocular involvement in patients with IgAN is infre-
quent, and the most common association is with uveitis
[8–11]. Other ophthalmic manifestations that are present
with IgAN are episcleritis [12, 13], scleritis [14, 15],
retinal vasculitis [8], serous retinal detachment [16],
ciliochoroidal effusion [17], and Vogt–Koyanagi–Harada
syndrome. [18]
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The ocular involvement could be related to immunopatho-
genic alterations probably associated with the dysregulation of
innate immunity and complement system activation [5] and
also related with systemic complications such as renal failure
and hypertension [19]. We present a case of IgAN associated
with bilateral nodular scleritis, first diagnosed as Wegener's
granulomatosis, with IgAN confirmed after renal biopsy.
Case report
A 42-year-old man was referred due to a 1-month history of
redness, ocular pain, and blurred vision in both eyes. His
past medical history included acute otitis media complicated
with bacterial pneumonia 1 year previous. He later pre-
sented with renal failure and arterial hypertension. He also
had had diabetes for the past 10 years.
Ophthalmic examination revealed a visual acuity of 20/50
OD and 20/80 OS. There was an immovable, tender, inflamed
scleral nodule on the temporal side of the sclera of the right
eye associated with diffuse superior scleral inflammation and
thinning of the cornea at IX meridian (Fig. 1). In the left eye,
there were two nodules in the temporal and superior sclera
associated with diffuse scleral inflammation (Fig. 2). The
anterior chamber was deep with 0.5+ cells (Standardiza-
tion of Uveitis Nomenclature Working Group [20]) in the
OD and no cells in OS. The rest of the examination was
normal. The diagnosis of bilateral nodular scleritis and
sclerokeratitis in OD was made; because of the clinical
and systemic findings, Wegener's granulomatosis was
considered, and high-dose steroid treatment was begun
after infectious causes were ruled out.
Laboratory tests included a complete blood count, an
erythrocyte sedimentation rate, antinuclear antibodies, liver
enzymes, c-ANCA and p-ANCA, CRP, urinalysis, chest x-
ray, thoracic CT, VDRL, a fluorescent treponemal antibody
absorption test, and a purified protein derivative skin test for
tuberculosis. Serum urea nitrogen was 94 mg/dl and serum
creatinine was 2.7 mg/dl; antinuclear antibodies were found
to be 1:20 and were considered negative. The rest of the
laboratory assessment was negative.
Kidney biopsy was performed because both antineutrophil
cytoplasmic antibodies (c- and p-ANCA) and antibodies to
proteinase-3 andmyeloperoxidase were negative, and thoracic
CT abnormalities were not found. Pathologic findings con-
sisted of an adequate kidney biopsy (28 glomeruli) with 53%
global glomerulosclerosis, moderate tubular atrophy, and
moderate interstitial fibrosis. The rest of the glomeruli showed
diffuse proliferative mesangial hypercellularity with an in-
crease of the mesangial matrix. The biopsy did not show
endocapillary hypercellularity, crescents, segmental sclerosis,
glomerulitis, vasculitis, or necrosis. Glomerular basal mem-
brane thickness was normal. Immunofluorescence demon-
strated granular deposits of IgA in a mesangial pattern with
strong intensity (4 out of 4 points). Glomerular staining for
IgG, IgM, lambda with less intensity (2 out of 4 points), and
kappa predominance (3 out of 4 points) were also found.
Others markers such as C1q, C3c, C4c, fibrin, and albumin
were negative (Fig. 3).
After one monthly pulse of IV cyclophosphamide thera-
py, the scleral nodules resolved completely, and there was
development of mild scleral thinning. At 2 years of follow-
up with azathioprine, there are no recurrences, and mild
renal failure is stable.
Fig. 1 Right eye. a Slit-lamp
photograph with low magnifi-
cation showing an inflamed,
elevated, immobile, scleral
nodule in the temporal part of
the sclera. b Slit-lamp photo-
graph with ×16 magnification
showing diffuse superior scleral
inflammation. c Slit-lamp pho-
tograph with ×16 magnification
showing the temporal sclera
nodule. d Slit-lamp photograph
with ×16 magnification show-
ing thinning of the cornea at IX
meridian
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Discussion
IgA nephropathy is the most common form of primary
glomerular disease in the developed world [4]. Of the pri-
mary glomerular diseases, IgA nephropathy and isolated
mesangial C3 deposits have been associated with scleritis
and episcleritis [12, 14].
In IgAN, the deposits of IgA are frequently associated
with complement components. The alternative pathway
components C3 and properdin, and the membrane attack
complex, are generally found in the mesangial deposits in
IgAN, while the classical pathway components C1q and C4
are usually absent [21].
The role of circulating immune complexes in the patho-
genesis of IgAN is controversial. Hall and coworkers [22]
found IgA circulating immune complexes in patients with
early stages of the disease, and Sirbat and associates [12]
found numerous dimeric-IgA-secreting cells in an episcleral
biopsy obtained from a female patient with IgAN and fre-
quent episodes of episcleritis.
Nomoto and coworkers [14] followed 113 patients with
various types of primary glomerular diseases for 1–33 months
and verified that, of the patients studied, six exhibited scleritis.
All of these six patients with scleritis were identified as having
IgAN. Importantly, none of the patients other than those with
IgAN had scleritis during the study period.
Fig. 2 Left eye. a Slit-lamp
photograph with low magnifi-
cation showing an inflamed,
elevated, immobile, scleral
nodule in the temporal part of
the sclera. b Slit-lamp photo-
graph with ×16 magnification
showing a superior nodular
scleritis. c Slit-lamp photograph
with ×16 magnification showing
the temporal sclera nodule.
d Slit-lamp photograph with ×16
magnification demonstrating
purple coloration of the sclera
Fig. 3 a H&E, ×10. Interstitial
fibrosis and tubular atrophy.
b H&E, ×40. Mesangial
hyperplasia. c IF-IgA, ×5.
Positive glomeruli and negative
interstice. d IF-IgA, ×40.
Mesangial and granular pattern
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This case fits the systemic patterns of IgAN previously
reported [5, 23]. Our patient began with an acute upper
airway infection that often precedes clinical exacerbation
of IgA nephropathy. Arterial hypertension can be present
in 29 to 36% of these patients at the beginning of the
disease.
The most important differential diagnosis considered was
Wegener's granulomatosis. The negative laboratory results
and the normal chest x-ray and thoracic CT suggested a
kidney biopsy to confirm the diagnosis.
In patients with scleritis and renal and urine abnormalities
associated with a history of upper airway infection, IgAN
should be considered and investigated. We hypothesize that
the abnormalities of the IgA immune system, similar to
those of IgA nephropathy, may be involved in the develop-
ment of scleritis.
Conclusion
In summary, we present a case of scleritis and sclerokeratitis
associated with IgA nephropathy in a patient with a history
of an acute upper airway infection and later development of
nephropathy and hypertension. Negative imaging and labo-
ratory findings suggested the need of a kidney biopsy for the
differential diagnosis between Wegener's granulomatosis
and IgA nephropathy.
Acknowledgments We thank Sergio Lozano-Rodriguez, M.D., for
reviewing the manuscript.
Conflict of interest The authors report no conflicts of interest. The
authors alone are responsible for the content and writing of the paper.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution License which permits any use, distribution
and reproduction in any medium, provided the original author(s) and
the source are credited.
References
1. Jabs DA, Mudun A, Dunn JP, Marsh MJ (2000) Episcleritis and
scleritis: clinical features and treatment results. Am J Ophthalmol
130(4):469–476
2. Okhravi N, Odufuwa B, McCluskey P, Lightman S (2005)
Scleritis. Surv Ophthalmol 50(4):351–363. doi:10.1016/
j.survophthal.2005.04.001
3. Berger J (1969) IgA glomerular deposits in renal disease. Trans-
plant Proc 1(4):939–944
4. McGrogan A, Franssen CF, de Vries CS (2011) The incidence of
primary glomerulonephritis worldwide: a systematic review of the
literature. Nephrol Dial Transplant 26(2):414–430. doi:10.1093/
ndt/gfq665
5. Coppo R, Amore A, Peruzzi L, Vergano L, Camilla R (2010)
Innate immunity and IgA nephropathy. J Nephrol 23(6):626–632
6. Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med
347(10):738–748. doi:10.1056/NEJMra020109
7. Mustonen J (1984) IgA glomerulonephritis and associated dis-
eases. Ann Clin Res 16(3):161–166
8. O'Neill D, Harvey P, Longstaff S, Brown CB (1994) Retinal
vasculitis and uveitis in IgA nephritis. Eye (Lond) 8(Pt 6):711–713
9. Moller-Jensen J, Marthinsen L, Linne T (1989) Anterior uveitis in
IgA nephropathy. Am J Ophthalmol 108(5):604–605
10. Yamabe H, Ozawa K, Fukushi K, Kubota H, Ohsawa H, Akitsu H,
Chiba N, Seino S, Miyata M, Onodera K et al (1988) IgA ne-
phropathy and Henoch-Schonlein purpura nephritis with anterior
uveitis. Nephron 50(4):368–370
11. Pascual J, Liano F, Mampaso F, Bellas C, Teruel JL, Ortuno J
(1991) IgA nephropathy and acute interstitial nephritis in a patient
with relapsing uveitis and longstanding AS. J Rheumatol 18
(6):942–945
12. Sirbat D, Saudax E, Hurault de Ligny B, Bene MC, Raspiller A
(1983) A new etiology of episcleritis: nephropathies with IgA and/
or isolated C3 deposits. J Fr Ophtalmol 6(11):921–925
13. Hegde V, Mitrut I, Bennett H, Singh J (2009) Episcleritis: an
association with IgA nephropathy. Cont Lens Anterior Eye 32
(3):141–142. doi:10.1016/j.clae.2008.12.007
14. Nomoto Y, Sakai H, Endoh M, Tomino Y (1980) Scleritis and IgA
nephropathy. Arch Intern Med 140(6):783–785
15. Endoh M, Kaneshige H, Tomino Y, Nomoto Y, Sakai H, Arimori
S, Shinbo T, Ishihara T (1981) IgA nephropathy associated with
myasthenia gravis and scleritis. Tokai J Exp Clin Med 6(4):421–
425
16. Kwok AK, Cheng LL, Bhende P, Lam DS, Sharma T (2000) Tear
of the retinal pigment epithelium and serous retinal detachment in
a case of IgA nephropathy after renal transplantation. Arch Oph-
thalmol 118(4):582–583
17. Pavlin CJ, Easterbrook M, Harasiewicz K, Foster FS (1993) An
ultrasound biomicroscopic analysis of angle-closure glaucoma
secondary to ciliochoroidal effusion in IgA nephropathy. Am J
Ophthalmol 116(3):341–345
18. Matsuo T, Masuda I, Ota K, Yamadori I, Sunami R, Nose S (2007)
Vogt-Koyanagi-Harada syndrome in two patients with immuno-
globulin A nephropathy. Acta Med Okayama 61(5):305–309
19. Taban M, Chand D, Sears JE (2006) Ocular findings in IgA
nephropathy with renal failure and hypertension. J Pediatr Oph-
thalmol Strabismus 43(6):378–380
20. Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization
of uveitis nomenclature for reporting clinical data. Results of the
First International Workshop. Am J Ophthalmol 140(3):509–516
21. Wyatt RJ, Julian BA (1988) Activation of complement in IgA
nephropathy. Am J Kidney Dis 12(5):437–442
22. Hall RP, Stachura I, Cason J, Whiteside TL, Lawley TJ (1983)
IgA-containing circulating immune complexes in patients with IgA
nephropathy. Am J Med 74(1):56–63
23. D'Amico G, Imbasciati E, Barbiano Di Belgioioso G, Bertoli S,
Fogazzi G, Ferrario F, Fellin G, Ragni A, Colasanti G, Minetti L et
al (1985) Idiopathic IgA mesangial nephropathy. Clinical and
histological study of 374 patients. Med (Baltim) 64(1):49–60
210 J Ophthal Inflamm Infect (2012) 2:207–210
